Literature DB >> 3878872

Kinetics of drug action in disease states. XV: Effect of pregnancy on the convulsive activity of pentylenetetrazol in rats.

I M Ramzan, G Levy.   

Abstract

The purpose of this investigation was to determine whether the pharmacodynamics of the central nervous system stimulant pentylenetetrazol (1) are altered in advanced pregnancy. Lewis rats that were 20 days pregnant and nonpregnant rats of the same age and strain received either a relatively fast or a relatively slow intravenous infusion of 1 until the onset of a maximal seizure, which occurred after about 11 or 31 min, respectively, of infusion. The concentrations of 1 at that time in serum, cerebrospinal fluid, (CSF) and brain were independent of the infusion rate and did not differ significantly between pregnant and nonpregnant animals. The ratio of concentrations of 1 in the cerebrospinal fluid to that in serum was unity in all groups, consistent with negligible serum protein binding and indicative of rapid penetration of 1 into the central nervous system. It is concluded that advanced pregnancy has no apparent effect on the response of the central nervous system of rats to the convulsive activity of 1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878872     DOI: 10.1002/jps.2600741119

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Electroencephalographic characterization of pentylenetetrazole kindling in rats and modulation of epileptiform discharges by nitric oxide.

Authors:  Victoria Bartsch; Javier Díaz; Ignacio González; Gabriel Cavada; Adrián Ocampo-Garcés; Ursula Wyneken
Journal:  Neurochem Res       Date:  2014-01-11       Impact factor: 3.996

2.  Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures.

Authors:  Sanjay N Rakhade; Erin F Fitzgerald; Peter M Klein; Chengwen Zhou; Hongyu Sun; Richard L Huganir; Richard L Hunganir; Frances E Jensen
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.